Workflows
Genetic Medicine
Overview
Vaccines
Gene Therapy
Cell Therapy
Diseases Applications
Overview
Oncology
Rare Diseases
Infectious Diseases
Drug Payloads
Overview
mRNA
siRNA
Plasmids
Small Molecules
Proteins and Peptides
Drug Carriers
Overview
Lipid Nanoparticles
Liposomes
Polymeric Nanoparticles
Platform Technologies
NanoAssemblr Platform
Overview
NxGen Technology
Spark
Ignite
Blaze
GMP System
GenVoy Platform
Overview
GenVoy-ILM
Clinical Lipid Nanoparticles
RNA Platform
Partnering
Partner With Us
Expertise
Overview
Clinical Solutions
Formulation Solutions
Our Partners
Resources and Community
What is Genetic Medicine
What is Nanomedicine
Resource Center
Overview
Publications
Posters
Webinars & Videos
Application Notes
Learning Paths
Overview
Events
NanoMedU
Get Started
Search
x
From Concept to Reality: Development of Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics - Martin Maier, Alnylam
Home
Resource Center
Videos & Webinars
Nucleic Acid Lipid Nanoparticles
siRNA
Genetic Medicine
Video
September 14, 2018
SHARE
3rd annual Nanomedicine Symposium in Midtown New York City July 21, 2018
Martin A. Maier, PhD - Vice President of Research at Alnylam Pharmaceuticals
limit search to this category
Advanced Search
All
Publications
Application Notes
Posters
Workshops
Videos & Webinars
Advanced Search
close
Publications
Application Notes
Posters
Workshops
Videos & Webinars
Blog Posts
Search
Browse by Category
Application
Diagnostic and Imaging
Genetic Medicine
Hematology
Metabolic Disorders
Neuroscience
Oncology
Skeletal Disorders
Targeted Drug Delivery
Vaccines
Other Applications
Formulation
Liposomes
Nucleic Acid Lipid Nanoparticles
Polymeric Nanoparticles
Other Formulations
Payload
DNA
microRNA
mRNA
siRNA
Small Molecule Drugs
Other Payloads